|SCOP2||1bet / SCOPe / SUPFAM|
They belong to a class of growth factors, secreted proteins that can signal particular cells to survive, differentiate, or grow. Growth factors such as neurotrophins that promote the survival of neurons are known as neurotrophic factors. Neurotrophic factors are secreted by target tissue and act by preventing the associated neuron from initiating programmed cell death – allowing the neurons to survive. Neurotrophins also induce differentiation of progenitor cells, to form neurons.
Although the vast majority of neurons in the mammalian brain are formed prenatally, parts of the adult brain (for example, the hippocampus) retain the ability to grow new neurons from neural stem cells, a process known as neurogenesis. Neurotrophins are chemicals that help to stimulate and control neurogenesis.
According to the United States National Library of Medicine's medical subject headings, the term neurotrophin may be used as a synonym for neurotrophic factor, but the term neurotrophin is more generally reserved for four structurally related factors: nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4). The term neurotrophic factor generally refers to these four neurotrophins, the GDNF family of ligands, and ciliary neurotrophic factor (CNTF), among other biomolecules. Neurotrophin-6 and neurotrophin-7 also exist but are only found in zebrafish.
During the development of the vertebrate nervous system, many neurons become redundant (because they have died, failed to connect to target cells, etc.) and are eliminated. At the same time, developing neurons send out axon outgrowths that contact their target cells. Such cells control their degree of innervation (the number of axon connections) by the secretion of various specific neurotrophic factors that are essential for neuron survival. One of these is nerve growth factor (NGF or beta-NGF), a vertebrate protein that stimulates division and differentiation of sympathetic and embryonic sensory neurons. NGF is mostly found outside the central nervous system (CNS), but slight traces have been detected in adult CNS tissues, although a physiological role for this is unknown. It has also been found in several snake venoms.
In the peripheral and central neurons, neurotrophins are important regulators for survival, differentiation, and maintenance of nerve cells. They are small proteins that secrete into the nervous system to help keep nerve cells alive. There are two distinct classes of glycosylated receptors that can bind to neurotrophins. These two proteins are p75 (NTR), which binds to all neurotrophins, and subtypes of Trk, which are each specific for different neurotrophins. The reported structure above is a 2.6 Å-resolution crystal structure of neurotrophin-3 (NT-3) complexed to the ectodomain of glycosylated p75 (NRT), forming a symmetrical crystal structure.
Nerve growth factor
Nerve growth factor (NGF), the prototypical growth factor, is a protein secreted by a neuron's target cell. NGF is critical for the survival and maintenance of sympathetic and sensory neurons. NGF is released from the target cells, binds to and activates its high affinity receptor TrkA on the neuron, and is internalized into the responsive neuron. The NGF/TrkA complex is subsequently trafficked back to the neuron's cell body. This movement of NGF from axon tip to soma is thought to be involved in the long-distance signaling of neurons.
Brain-derived neurotrophic factor
Brain-derived neurotrophic factor (BDNF) is a neurotrophic factor found originally in the brain, but also found in the periphery. To be specific, it is a protein that has activity on certain neurons of the central nervous system and the peripheral nervous system; it helps to support the survival of existing neurons, and encourage the growth and differentiation of new neurons and synapses through axonal and dendritic sprouting. In the brain, it is active in the hippocampus, cortex, cerebellum, and basal forebrain — areas vital to learning, memory, and higher thinking. BDNF was the second neurotrophic factor to be characterized, after NGF and before neurotrophin-3.
BDNF is one of the most active substances to stimulate neurogenesis. Mice born without the ability to make BDNF suffer developmental defects in the brain and sensory nervous system, and usually die soon after birth, suggesting that BDNF plays an important role in normal neural development.
Despite its name, BDNF is actually found in a range of tissue and cell types, not just the brain. Expression can be seen in the retina, the CNS, motor neurons, the kidneys, and the prostate. Exercise has been shown to increase the amount of BDNF and therefore serve as a vehicle for neuroplasticity.
Neurotrophin-3, or NT-3, is a neurotrophic factor, in the NGF-family of neurotrophins. It is a protein growth factor that has activity on certain neurons of the peripheral and central nervous system; it helps to support the survival and differentiation of existing neurons, and encourages the growth and differentiation of new neurons and synapses. NT-3 is the third neurotrophic factor to be characterized, after NGF and BDNF.
NT-3 is unique among the neurotrophins in the number of neurons it has potential to stimulate, given its ability to activate two of the receptor tyrosine kinase neurotrophin receptors (TrkC and TrkB). Mice born without the ability to make NT-3 have loss of proprioceptive and subsets of mechanoreceptive sensory neurons.
DHEA and DHEA sulfate
The endogenous steroids dehydroepiandrosterone (DHEA) and its sulfate ester, DHEA sulfate (DHEA-S), have been identified as small-molecule agonists of the TrkA and p75NTR with high affinity (around 5 nM), and hence as so-called "microneurotrophins". DHEA has also been found to bind to the TrkB and TrkC, though while it activated the TrkC, it was unable to activate the TrkB. It has been proposed that DHEA may have been the ancestral ligand of the Trk receptors early on in the evolution of the nervous system, eventually being superseded by the polypeptide neurotrophins.
Role in programmed cell death
During neuron development neurotrophins play a key role in growth, differentiation, and survival. They also play and important role in the apoptotic programmed cell death (PCD) of neurons. Neurotrophic survival signals in neurons are mediated by the high-affinity binding of neurotrophins to their respective Trk receptor. In turn, a majority of neuronal apoptotic signals are mediated by neurotrophins binding to the p75NTR. The PCD which occurs during brain development is responsible for the loss of a majority of neuroblasts and differentiating neurons. It is necessary because during development there is a massive over production of neurons which must be killed off to attain optimal function.
In the development of both the peripheral nervous system (PNS) and the central nervous system (CNS) the p75NTR-neurotrophin binding activates multiple intracellular pathways which are important in regulating apoptosis. Proneurotrophins (proNTs) are neurotrophins which are released as biologically active uncleaved pro-peptides. Unlike mature neurotrophins which bind to the p75NTR with a low affinity, proNTs preferentially bind to the p75NTR with high affinity. The p75NTR contains a death domain on its cytoplasmic tail which when cleaved activates an apoptotic pathway. The binding of a proNT (proNGF or proBDNF) to p75NTR and its sortilin co-receptor (which binds the pro-domain of proNTs) causes a p75NTR-dependent signal transduction cascade. The cleaved death domain of p75NTR activates c-Jun N-terminal kinase (JNK). The activated JNK translocates into the nucleus, where it phosphorylates and transactivates c-Jun. The transactivation of c-Jun results in the transcription of pro-apoptotic factors TFF-a, Fas-L and Bak. The importance of sortilin in p75NTR-mediated apoptosis is exhibited by the fact that the inhibition of sortilin expression in neurons expressing p75NTR suppresses proNGF-mediated apoptosis, and the prevention of proBDNF binding to p75NTR and sortilin abolished apoptotic action. Activation of p75NTR-mediated apoptosis is much more effective in the absence of Trk receptors due to the fact that activated Trk receptors suppress the JNK cascade.
The expression of TrkA or TrkC receptors in the absence of neurotrophins can lead to apoptosis, but the mechanism is poorly understood. The addition of NGF (for TrkA) or NT-3 (for TrkC) prevents this apoptosis. For this reason TrkA and TrkC are referred to as dependence receptors, because whether they induce apoptosis or survival is dependent on the presence of neurotrophins. The expression of TrkB, which is found mainly in the CNS, does not cause apoptosis. This is thought to be because it is differentially located in the cell membrane while TrkA and TrkC are co-localized with p75NTR in lipid rafts.
In the PNS (where NGF, NT-3 and NT-4 are mainly secreted) cell fate is determined by a single growth factor (i.e. neurotrophins). However, in the CNS (where BDNF is mainly secreted in the spinal cord, substantia nigra, amygdala, hypothalamus, cerebellum, hippocampus and cortex) more factors determine cell fate, including neural activity and neurotransmitter input. Neurotrophins in the CNS have also been shown to play a more important role in neural cell differentiation and function rather than survival. For these reasons, compared to neurons in the PNS, neurons of the CNS are less sensitive to the absence of a single neurotrophin or neurotrophin receptor during development; with the exception being neurons in the thalamus and substantia nigra.
Gene knockout experiments were conducted to identify the neuronal populations in both the PNS and CNS that were affected by the loss of different neurotrophins during development and the extent to which these populations were affected. These knockout experiments resulted in the loss of several neuron populations including the retina, cholinergic brainstem and the spinal cord. It was found that NGF-knockout mice had losses of a majority of their dorsal root ganglia (DRG), trigeminal ganglia and superior cervical ganglia. The viability of these mice was poor. The BDNF-knockout mice had losses of a majority of their vestibular ganglia and moderate losses of their DRG, trigeminal ganglia, nodose petrosal ganglia and cochlear ganglia. In addition they also had minor losses of their facial motoneurons located in the CNS. The viability of these mice was moderate. The NT-4-knockout mice had moderate losses of their nodose petrosal ganglia and minor losses of their DRG, trigeminal ganglia and vestibular ganglia. The NT-4-knockout mice also had minor losses of facial motoneurons. These mice were very viable. The NT-3 knockout mice had losses of a majority of their DRG, trigeminal ganglia, cochlear ganglia and superior cervical ganglia and moderate losses of nodose petrosal ganglia and vestibular ganglia. In addition the NT-3-knockout mice had moderate losses of spinal moroneurons. These mice had very poor viability. These results show that the absence of different neurotrophins result in losses of different neuron populations (mainly in the PNS). Furthermore, the absence of the neurotrophin survival signal leads to apoptosis.
- Hempstead BL (February 2006). "Dissecting the diverse actions of pro- and mature neurotrophins". Current Alzheimer Research. 3 (1): 19–24. doi:10.2174/156720506775697061. PMID 16472198. Archived from the original on 2009-08-30. Retrieved 2020-04-16.
- Reichardt LF (September 2006). "Neurotrophin-regulated signalling pathways". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 361 (1473): 1545–64. doi:10.1098/rstb.2006.1894. PMC 1664664. PMID 16939974.
- Allen SJ, Dawbarn D (February 2006). "Clinical relevance of the neurotrophins and their receptors". Clinical Science. 110 (2): 175–91. doi:10.1042/CS20050161. PMID 16411894.
- Eriksson PS, Perfilieva E, Björk-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH (November 1998). "Neurogenesis in the adult human hippocampus". Nature Medicine. 4 (11): 1313–7. doi:10.1038/3305. PMID 9809557.
- Neurotrophins at the US National Library of Medicine Medical Subject Headings (MeSH)
- Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 8: Atypical Neurotransmitters". In Sydor A, Brown RY (eds.). Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd ed.). New York: McGraw-Hill Medical. pp. 199, 215. ISBN 9780071481274.
Neurotrophic factors are polypeptides or small proteins that support the growth, differentiation, and survival of neurons. They produce their effects by activation of tyrosine kinases.
- Sanes, Dan H., Reh, Thomas A., Harris, William A. Development of the Nervous System. Academic Press, 2012, p.173-193.
- Sanes, Dan H. (2012). Development of the Nervous System. Academic Press. pp. 173–193.
- Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA (August 1990). "Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain". The EMBO Journal. 9 (8): 2459–64. doi:10.1002/j.1460-2075.1990.tb07423.x. PMC 552273. PMID 2369898.
- Wistow G, Piatigorsky J (June 1987). "Recruitment of enzymes as lens structural proteins". Science. 236 (4808): 1554–6. Bibcode:1987Sci...236.1554W. doi:10.1126/science.3589669. PMID 3589669.
- Bradshaw RA, Blundell TL, Lapatto R, McDonald NQ, Murray-Rust J (February 1993). "Nerve growth factor revisited". Trends in Biochemical Sciences. 18 (2): 48–52. doi:10.1016/0968-0004(93)90052-O. PMID 8488558.
- Koyama J, Inoue S, Ikeda K, Hayashi K (December 1992). "Purification and amino-acid sequence of a nerve growth factor from the venom of Vipera russelli russelli". Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1160 (3): 287–92. doi:10.1016/0167-4838(92)90090-Z. PMID 1477101.
- Inoue S, Oda T, Koyama J, Ikeda K, Hayashi K (February 1991). "Amino acid sequences of nerve growth factors derived from cobra venoms". FEBS Letters. 279 (1): 38–40. doi:10.1016/0014-5793(91)80244-W. PMID 1995338.
- Arévalo JC, Wu SH (July 2006). "Neurotrophin signaling: many exciting surprises!". Cellular and Molecular Life Sciences. 63 (13): 1523–37. doi:10.1007/s00018-006-6010-1. PMID 16699811.
- Harrington AW, Ginty DD (March 2013). "Long-distance retrograde neurotrophic factor signalling in neurons". Nature Reviews. Neuroscience. 14 (3): 177–87. doi:10.1038/nrn3253. PMID 23422909.
- Exercise builds brain health: key roles of growth factor cascades and inflammation by Carl W. Cotman, Nicole C. Berchtold and Lori-Ann Christie https://scholar.google.com/scholar?cluster=11830727319998892361&hl=en&as_sdt=0,10
- "Entrez database entry for NT-4/5". NCBI. Retrieved 2007-05-07.
- Prough RA, Clark BJ, Klinge CM (April 2016). "Novel mechanisms for DHEA action". Journal of Molecular Endocrinology. 56 (3): R139–55. doi:10.1530/JME-16-0013. PMID 26908835.
- Lazaridis I, Charalampopoulos I, Alexaki VI, Avlonitis N, Pediaditakis I, Efstathopoulos P, Calogeropoulou T, Castanas E, Gravanis A (April 2011). "Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis". PLOS Biology. 9 (4): e1001051. doi:10.1371/journal.pbio.1001051. PMC 3082517. PMID 21541365.
- Pediaditakis I, Iliopoulos I, Theologidis I, Delivanoglou N, Margioris AN, Charalampopoulos I, Gravanis A (January 2015). "Dehydroepiandrosterone: an ancestral ligand of neurotrophin receptors". Endocrinology. 156 (1): 16–23. doi:10.1210/en.2014-1596. PMID 25330101.
- Gravanis A, Calogeropoulou T, Panoutsakopoulou V, Thermos K, Neophytou C, Charalampopoulos I (October 2012). "Neurosteroids and microneurotrophins signal through NGF receptors to induce prosurvival signaling in neuronal cells". Science Signaling. 5 (246): pt8. doi:10.1126/scisignal.2003387. PMID 23074265.
- Sanes, Dan H.; Reh, Thomas A.; Harris, William A. (2012). Development of the Nervous System. Academic Press. pp. 173–193.
- Squire, Larry R.; Berg, Darwin; Bloom, Floyd E.; du Lac, Sascha; Ghosh, Anirvan; Spitzer, Nicholas C. (2013). Fundamental Neuroscience. Academic Press. pp. 405–435. ISBN 978-0-12-385870-2.
- Bamji SX, Majdan M, Pozniak CD, Belliveau DJ, Aloyz R, Kohn J, Causing CG, Miller FD (February 1998). "The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death". The Journal of Cell Biology. 140 (4): 911–23. doi:10.1083/jcb.140.4.911. PMC 2141754. PMID 9472042.
- Lu B, Pang PT, Woo NH (August 2005). "The yin and yang of neurotrophin action". Nature Reviews. Neuroscience. 6 (8): 603–14. doi:10.1038/nrn1726. PMID 16062169.
- Nikoletopoulou V, Lickert H, Frade JM, Rencurel C, Giallonardo P, Zhang L, Bibel M, Barde YA (September 2010). "Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not" (PDF). Nature. 467 (7311): 59–63. Bibcode:2010Natur.467...59N. doi:10.1038/nature09336. hdl:10261/27437. PMID 20811452.
- Teng KK, Felice S, Kim T, Hempstead BL (April 2010). "Understanding proneurotrophin actions: Recent advances and challenges". Developmental Neurobiology. 70 (5): 350–9. doi:10.1002/dneu.20768. PMC 3063094. PMID 20186707.
- Dhanasekaran DN, Reddy EP (October 2008). "JNK signaling in apoptosis". Oncogene. 27 (48): 6245–51. doi:10.1038/onc.2008.301. PMC 3063296. PMID 18931691.
- Huang EJ, Reichardt LF (2001). "Neurotrophins: roles in neuronal development and function". Annual Review of Neuroscience. 24: 677–736. doi:10.1146/annurev.neuro.24.1.677. PMC 2758233. PMID 11520916.
- Longo FM, Massa SM (July 2013). "Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease". Nature Reviews. Drug Discovery. 12 (7): 507–25. doi:10.1038/nrd4024. PMID 23977697.
- Yoon SO, Casaccia-Bonnefil P, Carter B, Chao MV (May 1998). "Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival". The Journal of Neuroscience. 18 (9): 3273–81. doi:10.1523/JNEUROSCI.18-09-03273.1998. PMC 6792655. PMID 9547236.
- Dekkers MP, Nikoletopoulou V, Barde YA (November 2013). "Cell biology in neuroscience: Death of developing neurons: new insights and implications for connectivity". The Journal of Cell Biology. 203 (3): 385–93. doi:10.1083/jcb.201306136. PMC 3824005. PMID 24217616.
- Lessmann V, Gottmann K, Malcangio M (April 2003). "Neurotrophin secretion: current facts and future prospects". Progress in Neurobiology. 69 (5): 341–74. doi:10.1016/s0301-0082(03)00019-4. PMID 12787574.
- Ernsberger U (June 2009). "Role of neurotrophin signalling in the differentiation of neurons from dorsal root ganglia and sympathetic ganglia". Cell and Tissue Research. 336 (3): 349–84. doi:10.1007/S00441-009-0784-Z. PMID 19387688.
- DevBio.com - 'Neurotrophin Receptors: The neurotrophin family consists of four members: nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4 (NT-4)' (April 4, 2003)
- Dr.Koop.com - 'New Clues to Neurological Diseases Discovered: Findings could lead to new treatments, two studies suggest', Steven Reinberg, HealthDay (July 5, 2006)
- Helsinki.fi - 'Neurotrophic factors'
- Neurotrophins at the US National Library of Medicine Medical Subject Headings (MeSH)
-  - Neurotrophin-3 image